MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Neuromelanin"

  • 2026 International Congress

    Neuromelanin-Sensitive MRI as a Marker of Clinical Severity and Disease Burden in Parkinson’s Disease

    R. Akande, T. Kustermann, S. Holiga, J. Anzures-Cabrera, G. Pagano (Basel, Switzerland)

    Objective: To quantify associations between neuromelanin-sensitive MRI (NM-MRI) metrics and clinical severity and cumulative disease burden markers in Parkinson’s disease (PD). Background: NM-MRI visualises neuromelanin-containing…
  • 2026 International Congress

    Multi-Sequence MRI-Based Machine Learning Model for Differentiating Parkinson Disease (PD) from Multiple System Atrophy (MSA)

    Y. Wang, N. He, M. Haacke, F. Yan, G. Yang, P. Lewitt (Shanghai, China)

    Objective: To develop a multi-sequence MRI-based machine learning model differentiating PD from MSA. Background: MRI protocols capable of distinguishing PD from MSA are greatly needed.…
  • 2026 International Congress

    Subtype-specific alterations of iron deposition and neuromelanin loss in the substantia nigra of Parkinson’s disease

    A. Shima, Y. Sakato, R. Sakai, Y. Terada, D. Kambe, A. Nishida, K. Yoshimura, H. Sakamaki, I. Wada, M. Sawamura, E. Nakanishi, H. Yamakado, S. Okuchi, T. Okada, Y. Fushimi, Y. Nakamoto, R. Takahashi, R. Matsumoto, N. Sawamoto (Kyoto, Japan)

    Objective: To investigate the specific pathological changes in the substantia nigra (SN) across  Parkinson’s disease (PD) subtypes, focusing on iron deposition and NM depletion both…
  • 2026 International Congress

    Extracellular Neuromelanin Promotes Microglial Reactivity in Parkinson’s Disease

    S. Smajic, V. Florentin, J. Ghelfi, K. Badanjak, S. Delcambre, C. Morris, J. Schwamborn, M. Spielmann, P. Antony, I. Goglia, A. Grünewald (Belval Esch-sur-Alzette, Luxembourg)

    Objective: To investigate the interaction between neuromelanin (NM) and microglia in Parkinsons’s Disease (PD) using human post-mortem midbrain tissue and induced pluripotent stem cell (iPSC)…
  • 2026 International Congress

    Neuromelanin Loss Is Associated with Increased Substantia Nigra Free-Water: a Longitudinal Study of Controls, RBD, and PD

    V. Madge, K. Wennberg, R. Klevor, A. Dagher, R. Postuma, D L. Collins (Montréal, Canada)

    Objective: To longitudinally characterize substantia nigra (SN) neuromelanin (NM) and free-water (FW) MRI biomarkers by comparing control, REM sleep behaviour disorder (RBD), and Parkinson’s disease…
  • 2024 International Congress

    Assessment Of The Effect Of Sleep Deprivation And Essential Amino Acid Deficient Diet (Tryptophan) On Growth And Cognition In Wistar Rats

    L. Usman, R. Ibrahim, H. Abdulameed, E. Ajani, A. Akinmoladun (Kepala Batas, Malaysia)

    Objective: This study explores the interplay encompassing amino acids' roles, metabolic processes, growth, and the intricate relationships between sleep patterns, amino acid-deficient diet, and caffeine…
  • 2024 International Congress

    AI based longitudinal changes in substantia nigra contrast and volume on neuromelanin MRI and its relation to clinical markers in a multi-site Parkinson’s disease study.

    M. Ingalhalikar, H. Pham, T. G, L. Bracoud, MH. Hutchison, K. Evans, T. Dam, KN. Nguyen, CC. Conklin, JS. Suhy, DS. Scott (San Mateo, USA)

    Objective: To apply an AI model in a multi-site longitudinal study to segment substantia nigra pars compacta (SNpc), perform longitudinal analysis, and quantify its association…
  • 2023 International Congress

    Neuromelanin related 7T MRI of the locus coeruleus differs between Parkinson’s disease and controls

    A. Wolters, M. Heijmans, N. Priovoulos, H. Jacobs, A. Postma, Y. Temel, M. Kuijf, S. Michielse (Maastricht, Netherlands)

    Objective: To compare the signal intensity of the substantia nigra and locus coeruleus on Magnetization Transfer 7T MRI between PD patients and healthy controls (HC)…
  • 2023 International Congress

    Morphometric assessment of age-associated neuronal changes in the human locus coeruleus

    A. Bhattacharya, A. Mahadevan, R. Manjithaya, T. Yasha, P. Alladi (Bengaluru, India)

    Objective: To delineate the age-related changes in the neuronal size and neuromelanin (NM) intensity in autopsied tissues of human locus coeruleus (LC). Background: Many studies…
  • 2023 International Congress

    Preliminary Report on Neuromelanin-Sensitive MRI Signal change after Allogeneic Bone marrow-derived Mesenchymal Stem Cells therapy: Phase IIa double-blind, randomized controlled trial

    J. Suescun, M. Schiess, E. Rodarte, C. Adams, T. Ellmore (Houston, USA)

    Objective: To select the most effective number of repeat doses of mesenchymal stem cells (MSC) delivered intravenously to slow the progression of Parkinson’s disease (PD).…
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley